JMP Securities reiterated their market outperform rating on shares of Neuronetics (NASDAQ:STIM – Get Rating) in a report published on Wednesday, Benzinga reports. JMP Securities currently has a $12.00 price target on the stock.
Separately, Canaccord Genuity Group lifted their target price on shares of Neuronetics from $9.00 to $10.00 in a report on Wednesday, November 9th.
Neuronetics Trading Down 10.9 %
Shares of STIM opened at $3.75 on Wednesday. The company has a current ratio of 4.02, a quick ratio of 3.68 and a debt-to-equity ratio of 0.43. The company’s fifty day moving average is $5.94 and its two-hundred day moving average is $4.81. Neuronetics has a fifty-two week low of $1.98 and a fifty-two week high of $6.95.
Insider Transactions at Neuronetics
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Y Intercept Hong Kong Ltd acquired a new stake in shares of Neuronetics in the 2nd quarter worth approximately $35,000. PDT Partners LLC acquired a new stake in Neuronetics during the third quarter valued at approximately $38,000. Baker Tilly Wealth Management LLC acquired a new stake in Neuronetics during the third quarter valued at approximately $40,000. CWM LLC acquired a new stake in Neuronetics during the third quarter valued at approximately $41,000. Finally, Prudential Financial Inc. acquired a new stake in Neuronetics during the third quarter valued at approximately $45,000. 62.90% of the stock is owned by institutional investors and hedge funds.
Neuronetics Company Profile
Neuronetics, Inc commercial stage medical technology company, which engages in the designing, developing and marketing products for the patients suffering from psychiatric disorders. It operates through United States and International geographical segments. The firm offers NeuroStar TMS, a therapy system for the treatment of major depressive disorders in adult patients.
- Get a free copy of the StockNews.com research report on Neuronetics (STIM)
- META Platforms May See its Biggest Opening Yet for New Highs
- Penny Stock Vinco Ventures Could Be Big Winner
- Is Chip Design Specialist Synopsys A Gem Hiding In Plain Sight?
- Should You Park Some Capital with Casey’s General Stores?
- Crowdstrike Stock: While The Iron Is Hot!
Receive News & Ratings for Neuronetics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neuronetics and related companies with MarketBeat.com's FREE daily email newsletter.